Oregon Liquor Control Commission

Chalice Brands Ltd. Open Letter to Shareholders

Retrieved on: 
Tuesday, August 23, 2022

PORTLAND, Ore., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (the Company or Chalice Brands), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, announced today that it has issued the following open letter to shareholders from the Chalice Brands leadership team.

Key Points: 
  • PORTLAND, Ore., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (the Company or Chalice Brands), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, announced today that it has issued the following open letter to shareholders from the Chalice Brands leadership team.
  • On behalf of everyone at Chalice Brands Ltd., we would first and foremost like to express gratitude to all our shareholders for their continued support of Chalice Brands.
  • Chalice Brands senior management team will continue to work closely with the Board to ensure accountability and transparency for shareholders.
  • The Company is committed to developing a dynamic portfolio built around the recognized brands of Chalice Brands, including Chalice Farms, Left Coast Connection, Homegrown Oregon and Cannabliss & Co., with a focus on health and wellness.

RS Biotherapeutics Appoints Jeremy Plumb as Chief Cultivation Officer

Retrieved on: 
Monday, August 1, 2022

At Prf, Jeremy combined his decades of cannabis horticulture experience with cutting-edge technology to deliver previously unattainable consistency in product quality.

Key Points: 
  • At Prf, Jeremy combined his decades of cannabis horticulture experience with cutting-edge technology to deliver previously unattainable consistency in product quality.
  • Commenting on the appointment, Justin Molignoni, Chief Strategy Officer of RS BioTherapeutics said, We are honored to welcome Jeremy Plumb to our talented leadership team.
  • Jeremy Plumb said, I am very excited to join the RS BioTherapeutics team and support the research, development, and commercialization of forward-thinking endocannabinoid system-focused interventions to address chronic and acute pulmonary inflammation-based diseases.
  • Founded by experts in pulmonary diseases and the endocannabinoid system, RS BioTherapeutics is a wholly owned subsidiary of Real Science Holdco LLC.

Chalice Brands Ltd. Enters Into Amended Agreement to Acquire Cannabliss & Co. Retail Locations

Retrieved on: 
Tuesday, July 5, 2022

Amending the original transaction allows us to better match the considerations to be paid with the expected cashflows of Cannabliss.

Key Points: 
  • Amending the original transaction allows us to better match the considerations to be paid with the expected cashflows of Cannabliss.
  • Chalice Brands acquires four Cannabliss & Co. retail locations further expanding our statewide retail footprint in Oregon to a total of 18 locations with iconic dispensary locations added such as the Fire Station store in Southeast Portland.
  • Chalice Brands is a premier consumer-driven cannabis company specializing in production, processing, wholesale, distribution and retail, with 12 owned and 6 managed dispensaries in and around Portland, Oregon.
  • The Company is committed to developing a dynamic portfolio built around the recognized brands of Chalice Brands, including Chalice Farms, Left Coast Connection, Homegrown Oregon and Cannabliss & Co., with a focus on health and wellness.

/R E P E A T -- Halo Collective Reports First Quarter 2022 Financial Results; Book Value Per Share of $1.65 ($2.12 CAD)/

Retrieved on: 
Tuesday, May 17, 2022

Halo's book value- booking investments at actual adjust costs basis after impairments per IFRS guidelines- is $80.7 million.

Key Points: 
  • Halo's book value- booking investments at actual adjust costs basis after impairments per IFRS guidelines- is $80.7 million.
  • The planned spinout of Halo Tek Inc. is expected to result in a distribution to all Halo shareholders.
  • Akanda successfully listed the Akanda Shares on the Nasdaq Capital Market on March 15, 2022, under the ticker symbol "AKAN .
  • Upon closing the acquisition of PhytoCann, PhytoCann is expected to add substantial net revenue and EBITDA and an impressive CBD-based product lineup to Halo.

Halo Collective Reports First Quarter 2022 Financial Results; Book Value Per Share of $1.65 ($2.12 CAD)

Retrieved on: 
Tuesday, May 17, 2022

TORONTO, May 17, 2022 /PRNewswire/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) today announced its financial and operational results for three months ended March 31, 2022 ("Q1 2022").

Key Points: 
  • TORONTO, May 17, 2022 /PRNewswire/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) today announced its financial and operational results for three months ended March 31, 2022 ("Q1 2022").
  • Halo's book value- booking investments at actual adjust costs basis after impairments per IFRS guidelines- is $80.7 million.
  • The planned spinout of Halo Tek Inc. is expected to result in a distribution to all Halo shareholders.
  • Akanda successfully listed the Akanda Shares on the Nasdaq Capital Market on March 15, 2022, under the ticker symbol "AKAN .

Chalice Brands Ltd. Announces Final Closing and Amended Terms of Acquisition of Tozmoz Assets, A Premier Cannabis Extractor In Oregon

Retrieved on: 
Wednesday, December 22, 2021

Chalice has satisfied certain conditions by way of the previous consulting agreement with Tozmoz, resulting in zero cash due at closing.

Key Points: 
  • Chalice has satisfied certain conditions by way of the previous consulting agreement with Tozmoz, resulting in zero cash due at closing.
  • Founded in 2015 as one of the first OLCC licensed processors in Oregon, Tozmoz established itself as a premier cannabis extractor in the state.
  • Co-Founder of Tozmoz, Joel Klobas, will continue providing services to Chalice and will be employed by the Company as Vice President, Production.
  • Chalice Brands is a premier consumer-driven cannabis company specializing in production, processing, wholesale, distribution and retail, with twelve owned and four managed dispensaries in and around Portland, Oregon.

C21 Investments Receives Regulatory Approval for Transfer of Swell Companies' Oregon Licenses

Retrieved on: 
Wednesday, April 17, 2019

VANCOUVER, April 17, 2019 /CNW/ - C21 Investments, Inc. (CSE: CXXI) today announced that it has received approval from the Oregon Liquor Control Commission for the transfer of all the operating licenses of Swell Companies in Oregon.

Key Points: 
  • VANCOUVER, April 17, 2019 /CNW/ - C21 Investments, Inc. (CSE: CXXI) today announced that it has received approval from the Oregon Liquor Control Commission for the transfer of all the operating licenses of Swell Companies in Oregon.
  • In 2017, Swell shipped over 500,000 product units within Oregon and has more than doubled its product units shipped through existing sales channels in 2018.
  • "Consumption of cannabis concentrates, such as vapes and edibles, saw a 49%1 increase in Oregon in 2018," said Alleh Lindquist, CEO of Swell.
  • "Swell will fulfill a critical segment of our expansion strategy," said Robert Cheney, President and CEO of C21 Investments.